SUPERFLUID DX
Tissue-specific cell-free circulating RNA is a newly developed area for molecular diagnosis. Based on this powerful non-invasive approach, Molecular Stethoscope aims to transform healthcare by providing early insight into a patient’s healthy versus disease state.
SUPERFLUID DX
Social Links:
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2015-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.molecularstethoscope.com
Total Employee:
11+
Status:
Active
Contact:
(858)500-8500
Email Addresses:
[email protected]
Total Funding:
8.2 M USD
Technology used in webpage:
SPF Google Maps Google Google Cloud Google Apps For Business Google Maps API Microsoft Azure DNS Google Maps For Work Network Solutions DNS Google Cloud Iowa
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Aviceda Therapeutics
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
![]()
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Current Employees Featured
![]()


Founder
![]()

Investors List
![]()
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation investment in Series A - Superfluid Dx
WRQ Sciences
WRQ Sciences investment in Series A - Superfluid Dx
![]()
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation investment in Grant - Superfluid Dx
Pfizer
Pfizer investment in Seed Round - Superfluid Dx
DCVC
DCVC investment in Seed Round - Superfluid Dx
Index Ventures
Index Ventures investment in Seed Round - Superfluid Dx
AAF Management Ltd.
AAF Management Ltd. investment in Seed Round - Superfluid Dx
Official Site Inspections
http://www.molecularstethoscope.com
- Host name: 1410646.cloudwaysapps.com
- IP address: 165.227.236.179
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1

More informations about "Superfluid Dx"
Superfluid Dx - Crunchbase Company Profile & Funding
Tissue-specific cell-free circulating RNA is a newly developed area for molecular diagnosis. Based on this powerful non-invasive approach, Molecular Stethoscope aims to transform healthcare by providing early insight into a patient’s healthy …See details»
Molecular Stethoscope, Inc. establishes new Corporate …
Jan 4, 2022 · Molecular Stethoscope is a Precision Medicine biotechnology company pioneering a Next-Generation cf-mRNA Liquid Biopsy AI/ML Technology Platform.See details»
Molecular Stethoscope - LinkedIn
Molecular Stethoscope is an early stage, molecular diagnostics company engaged in transcriptomic research and development in San Diego, California.See details»
Molecular Stethoscope - Craft
Sep 29, 2021 · See insights on Molecular Stethoscope including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
About Us - Superfluid
He has co-founded over a dozen companies including Fluidigm (FLDM), Helicos Biosciences (HLCS), and Molecular Stethoscope. Steve is a physics and theoretical physics graduate of Stanford and Oxford Universities.See details»
Superfluid Dx | Alzheimer's Drug Discovery Foundation
Apr 7, 2022 · Blood-based liquid biopsies have recently emerged as an alternative for non-invasive examination of molecular alterations. In particular, circulating cell free-mRNA (cf …See details»
Molecular Stethoscope - Mayo Clinic
Jan 11, 2016 · Molecular Stethoscope Pioneering new approaches to biological measurement, Dr. Stephen Quake , a part of the Quake Group at Stanford, reviews research in biological measurement techniques in human genetics.See details»
Tina S. Nova - California Council on Science & Technology (CCST)
Tina S. Nova, Ph.D. is President and CEO of Molecular Stethoscope and has extensive experience in the creation of start-up companies and the commercialization of products with a …See details»
Molecular Stethoscope's cf-mRNA liquid biopsy machine learning …
Sep 7, 2022 · Molecular Stethoscope is a Precision Medicine biotechnology company pioneering a Next-Generation cf-mRNA Liquid Biopsy AI/ML Technology Platform. The Company is …See details»
Molecular Stethoscope, Inc. Announces Presentation at 16th …
Sep 29, 2021 · Molecular Stethoscope is a Precision Medicine company based in Silicon Valley, California, pioneering the Next-Generation cf-mRNA Liquid Biopsy Technology Platform.See details»
Molecular Stethoscope, Inc. Announces Presentation of Primary ...
Nov 16, 2021 · Molecular Stethoscope is a Precision Medicine company based in Silicon Valley, California, pioneering the Next-Generation cf-mRNA Liquid Biopsy Artificial …See details»
Molecular Stethoscope CEO and Key Executive Team | Craft.co
Molecular Stethoscope's President & CEO is Tina Nova. Other executives include Mike Nerenberg, SVP & Chief Medical Officer; Brent Vetter, Senior Director, Finance and 9 others. …See details»
Molecular Stethoscope, Inc. announces new investment from
Jun 7, 2022 · /CNW/ -- Molecular Stethoscope, a leading precision medicine company pioneering the next-generation cell-free mRNA (cf-mRNA) liquid biopsy, announced today...See details»
Molecular Stethoscope, Inc. establishes new Corporate ... - Newswire
Jan 4, 2022 · Molecular Stethoscope is a Precision Medicine biotechnology company pioneering a Next-Generation cf-mRNA Liquid Biopsy AI/ML Technology Platform.See details»
Molecular Stethoscope, Inc. Announces Presentation at 16th …
Sep 29, 2021 · Molecular Stethoscope is a Precision Medicine company based in Silicon Valley, California, pioneering the Next-Generation cf-mRNA Liquid Biopsy Technology Platform.See details»
Molecular Stethoscope Working to Validate a Diagnostic Test for...
Apr 12, 2016 · Molecular Stethoscope, Inc., announced it is working with 23 U.S. academic and medical institutions to further validate its blood-based early diagnostic and disease monitoring …See details»
Molecular Stethoscope, Inc. announces new investment from the …
Jun 7, 2022 · Investment by the ADDF will accelerate the translation of Molecular Stethoscope's cf-mRNA liquid biopsy technology platform into products and services for the diagnosis and …See details»
Molecular Stethoscope Early R&D Efforts Aimed at Future
Apr 14, 2016 · NEW YORK (GenomeWeb) – Protective of its IP stance and conscious of a long road to commercialization, liquid biopsy startup Molecular Stethoscope has shared few details …See details»
Molecular Stethoscope Announces Completion and Publication of …
Dec 14, 2020 · Study results highlight the Company's Next-Generation cf-mRNA Liquid Biopsy-Artificial Intelligence Technology Platform for characterization of Alzheimer's Disease.See details»
Molecular Stethoscope, Inc. Announces Presentation of Primary ...
Nov 16, 2021 · Molecular Stethoscope is a Precision Medicine company based in Silicon Valley, California, pioneering the Next-Generation cf-mRNA Liquid Biopsy Artificial …See details»